Dr. Easterling is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
900 Pacific Ave
4TH floor
Everett, WA 98201Phone+1 425-304-6165Fax+1 425-304-6162
Education & Training
- University of WashingtonFellowship, Maternal-Fetal Medicine, 1985 - 1987
- Oregon Health & Science University (OHSU Health)Residency, Obstetrics and Gynecology, 1981 - 1985
- University of North Carolina at Chapel Hill School of MedicineClass of 1981
Certifications & Licensure
- OR State Medical License 1982 - Present
- WA State Medical License 1985 - 2024
- MT State Medical License 2001 - 2003
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- Top MD Consumers Checkbook
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Treatment Approaches to Preeclampsia Start of enrollment: 2009 Oct 01
Publications & Presentations
PubMed
- 172 citationsSafety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trialMaged M. Costantine, Kirsten Cleary, Mary F. Hebert, Mahmoud Ahmed, Linda Morris Brown
American Journal of Obstetrics and Gynecology. 2016-06-01 - 302 citationsThe reporting of pre-existing maternal medical conditions and complications of pregnancy on birth certificates and in hospital discharge dataMona T. Lydon-Rochelle, Victoria L. Holt, Vicky Cárdenas, Jennifer C. Nelson, Thomas R. Easterling
American Journal of Obstetrics and Gynecology. 2005-07-01 - 11 citationsEffect of N-Acetyltransferase 2 Genotype on the Pharmacokinetics of Hydralazine During Pregnancy.Lyrialle W. Han, Rachel J. Ryu, Michael C. Cusumano, Thomas R. Easterling, Brian Phillips
Journal of Clinical Pharmacology. 2019-12-01
Press Mentions
- Nifedipine, Methyldopa, Labetalol 'Viable Initial Options' for Severe Hypertension in Pregnancy in Low ...August 7th, 2019
- Bipartisan Legislation to Prevent Maternal DeathsMarch 17th, 2017
- Pregnancy Almost Killed Her. Should She Try Again?March 7th, 2017
Grant Support
- University Of Washington Obstetric-Fetal Pharmacology Research UnitEunice Kennedy Shriver National Institute Of Child Health &Human Development2010–2012
- Renal Reserve In PregnancyNational Center For Research Resources1996–1997
- Treatment Of Hypertension In PregnancyNational Center For Research Resources1996
- Calcium Supplementation And Maternal HemodynamicsNational Center For Research Resources1996
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: